Inter-species horizontal transfer resulting in core-genome and niche-adaptive variation within Helicobacter pylori by Saunders, NJ et al.
BioMed CentralBMC Genomics
ssOpen AcceResearch article
Inter-species horizontal transfer resulting in core-genome and 
niche-adaptive variation within Helicobacter pylori
Nigel J Saunders*1, Prawit Boonmee2, John F Peden3 and Stephen A Jarvis2
Address: 1Bacterial Pathogenesis and Functional Genomics Group, The Sir William Dunn School of Pathology, University of Oxford, South Parks 
Road, Oxford, OX1 3RE, UK, 2Department of Computer Science, University of Warwick, Coventry, CV4 7AL,UK and 3Oxford University 
Bioinformatics Centre, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK
Email: Nigel J Saunders* - Nigel.Saunders@path.ox.ac.uk; Prawit Boonmee - Prawit.Boonmee@warwick.ac.uk; 
John F Peden - John.Peden@well.ox.ac.uk; Stephen A Jarvis - Stephen.Jarvis@warwick.ac.uk
* Corresponding author    
Abstract
Background: Horizontal gene transfer is central to evolution in most bacterial species. The
detection of exchanged regions is often based upon analysis of compositional characteristics and
their comparison to the organism as a whole. In this study we describe a new methodology
combining aspects of established signature analysis with textual analysis approaches. This approach
has been used to analyze the two available genome sequences of H. pylori.
Results: This gene-by-gene analysis reveals a wide range of genes related to both virulence
behaviour and the strain differences that have been relatively recently acquired from other
sequence backgrounds. These frequently involve single genes or small numbers of genes that are
not associated with transposases or bacteriophage genes, nor with inverted repeats typically used
as markers for horizontal transfer. In addition, clear examples of horizontal exchange in genes
associated with 'core' metabolic functions were identified, supported by differences between the
sequenced strains, including: ftsK, xerD and polA. In some cases it was possible to determine which
strain represented the 'parent' and 'altered' states for insertion-deletion events. Different signature
component lengths showed different sensitivities for the detection of some horizontally transferred
genes, which may reflect different amelioration rates of sequence components.
Conclusion: New implementations of signature analysis that can be applied on a gene-by-gene
basis for the identification of horizontally acquired sequences are described. These findings highlight
the central role of the availability of homologous substrates in evolution mediated by horizontal
exchange, and suggest that some components of the supposedly stable 'core genome' may actually
be favoured targets for integration of foreign sequences because of their degree of conservation.
Background
Helicobacter pylori is a bacterial pathogen associated with
gastritis, peptic ulcers, gastric adenocarcinoma, and rare
lymphomas [1]. It has a highly panmictic population
structure in which homologous recombination makes the
predominant contribution to sequence differences within
a highly diverse population structure [2]. The acquisition
of genes from other strains and species is by far the most
rapid evolutionary process. This occurs frequently without
loss of existing functions, is central to the evolution of
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and greatly influences inter-strain differences in gene
complement [3-5]. In this context, it is notable that none
of the traits typically used to differentiate E. coli from Sal-
monella can be attributed to point mutation genes but are
broadly attributable to horizontal exchange [6]. H. pylori
is relatively unusual in that it is a naturally transformable
Gram-negative species that does not appear to have a spe-
cies-specific DNA uptake sequence and appears to rely
upon its niche separation as a transformation barrier [7].
Disease associated H. pylori strains have been divided into
two types, type I being those that carry the cag pathogenic-
ity island [8] (cag PAI), which has a foreign species origin,
and are associated with more severe disease.
Dinucleotide composition is highly stable within a
genome and can distinguish between sequences from dif-
ferent species. Based upon its constancy the species com-
position is referred to as a 'genome signature' [9,10]. This
characteristic has been applied to assessments of DNA
metabolic processes such as methylation and base conver-
sion, DNA structure, and evolutionary relationships. It
has also become established as a method for the identifi-
cation of sequences that have been acquired by inter-spe-
cies horizontal transfer. For example, lateral transfer has
recently been shown using these methods for a tryp-
tophan pathway operon [11], the gain of additional met-
abolic functions in Pseudomonas putida [12], a
determination that many gain of function genes have
been acquired by E. coli rather than lost from S. typhi [13],
and more recently developed Bayesian methods based
upon similar premises have been used to assess global sig-
natures and determine the origins of some lateral transfer
events [14,15]. However there are problems associated
with this and other methods that use progressive 'walking
windows', and the larger the window the greater the prob-
lems. These result from the inclusion of intergenic
sequence, the inability to distinguish divergences due to a
single highly divergent gene from that from a cluster of
less divergent ones, and an inability to identify the limits
of the abnormal regions. In practice additional features
are necessary to determine the ends of such regions, such
as the location of repeats typical of pathogenicity islands
in H. pylori [16], or comparisons with other sequences as
in N. meningitidis strain MC58 [17]. In addition, diver-
gence scores are influenced by the size of the sampling
window used such that sampling effects limit analysis of
sequences shorter than about 800 bp (data not pre-
sented), and the need to use fixed window sizes prevents
gene by gene studies.
We describe the use of a linear implementation of signa-
ture analysis that can efficiently address a range of walking
window sizes using dinucleotide signatures (DNS) and
longer signatures. In addition, use of a new approach
based upon classical text analysis that allows analysis of
genomes gene-by-gene is described. Analysis of H. pylori
sequences, combined with comparisons of the identified
genes between genomes, reveals complex changes that
influence both niche-adaptive and core functions illus-
trating a previously unpredicted range of functions which
are continuously undergoing variation and selection.
Results and discussion
Genes were ranked on the basis of their divergence from
the mean genome composition. The degree of divergence
that is indicative of acquisition from other species is not
an absolute. The frequency with which genes are acquired,
the untypicality of the donated material, and the rate at
which they are ameliorated to the host sequence compo-
sition influence it. Strains J99 and 26695 had 53 (Table 1)
and 60 (Table 4) genes respectively with DNS that were >2
SD from the mean. Those with annotated functions
included genes from the cag pathogenicity island (6 and
5), vac and related toxins (3 and 4), and restriction-mod-
ification genes (2 and 4). On the basis of the similarities
determined in the H. pylori strain J99 sequence annota-
tion, 7 of the most divergent genes as determined by DNS
are not present in strain 26695. Likewise, 2 of the 50 most
divergent genes in strain 26695 are not present in strain
J99. This is consistent with the identification of genes
acquired from other species that have not extended to
both sequenced strains. It also suggests that a significant
proportion of the 6 to 7% of genes unique to one or other
strain [18] are inherent to the Helicobacter gene pool, but
are variably present in different strains rather than reflect-
ing recent foreign origins. Comparisons of a selection of
identified orthologous genes in the two strains are shown
in Figure 1.
It cannot be assumed that all genes identified in this man-
ner have been recently acquired. It is necessary to assess
the nature of the sequence to determine if its divergence
might be accounted for on the basis of features of the
encoded protein. For example, JHP0476/HP0527,
JHP1300/HP1408 and JHP0074/HP0080 include repeti-
tive sequences likely to account for their DNS divergence.
This type of analysis cannot be used to determine the pos-
sible foreign origin of such genes. Notably, the most diver-
gent cag PAI gene (the 1st and 2nd most divergent gene in
the whole genomes of strain 26695 and J99 respectively,
JHP0476/HP0527) has a highly complex repetitive struc-
ture and the size of the large divergent peak associated
with this island using previous methods is largely due to
the presence of this gene.
While a significant proportion of the genes identified in
this analysis are associated with regions including several
such genes and which share characteristics of islands of
horizontal transfer or pathogenicity islands, this is farPage 2 of 16
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analysis
DNS order JHP # annotation 26695 # 26695 DNS order TNS order HNS order
1 JHP0952 hypothetical protein HP0427 14 3 1355
2 JHP0476 cag pathogenicity island protein (cag7) HP0527 1 2 2
3 JHP0556 vacuolating cytotoxin (vacA) paralog HP0609/10 4/13 5 4
4 JHP0274 vacuolating cytotoxin (vacA) paralog HP0289 2 6 5
5 JHP0305 hypothetical protein HP0322 3 8 10
6 JHP0942 hypothetical protein HP0996 5 13 27
7 JHP0856 vacuolating cytotoxin (vacA) paralog HP0922 6 9 6
8 JHP0050 hypothetical protein HP0058 88 7 84
9 JHP1300 hypothetical protein HP1408 15 1 1
10 JHP1044 hypothetical protein HP1116 8 14 8
11 JHP0928 hypothetical protein NAH - 12 9
12 JHP0074 hypothetical protein HP0080 9 32 125
13 JHP0440 hypothetical protein HP0488 7 16 17
14 JHP1042 hypothetical protein HP1115 20 25 694
15 JHP1321 histidine and glutamine-rich metal-binding protein HP1432 46 4 49
16 JHP0934 hypothetical protein NAH - 15 95
17 JHP0495 cag island protein (cagA) HP0547 31 20 12
18 JHP0931 topoisomerase I (topA 3) NAH - 18 20
19 JHP0693 hypothetical protein HP0756 24 59 1490
20 JHP0632 N-methylhydantoinase HP0696 19 44 36
21 JHP0471 cag pathogenicity island protein (cag3) HP0522 11 35 62
22 JHP0438 outer membrane protein HP0486 26 67 145
23 JHP0026 hypothetical protein HP0030 45 36 64
24 JHP1084 outer membrane protein (omp26) HP1157 34 17 24
25 JHP0481 cag island protein (cagT) HP0532 23 70 558
26 JHP0052 hypothetical protein HP0059 43 24 120
27 JHP0336 hypothetical protein HP1089 12 51 54
28 JHP1426 iron(III) dicitrate transport protein (fecA) HP1400 32 78 111
29 JHP0174 hypothetical protein HP0187 / 8 
/ 6
47&1127&596 88 90
30 JHP1297 type III restriction enzyme (res) NAH - 63 28
31 JHP0953 hypothetical protein NAH - 26 1463
32 JHP0067 urease beta subunit (urea amidohydrolase) (ureB) HP0072 21 37 70
33 JHP0941 integrase/recombinase (xerD) HP0995 25 100 541
34 JHP0548 flagellin A (flaA) HP0601 33 40 154
35 JHP0299 hypothetical protein HP061/2 230&765 11 275
36 JHP1033 hypothetical protein HP1106 59 262 342
37 JHP1409 type II restriction enzyme (methyltransferase) NAH - 55 15
38 JHP0626 iron(III) dicitrate transport protein (fecA) HP0686 62 89 47
39 JHP0940 hypothetical protein NAH - 53 393
40 JHP1253 hypothetical protein HP1333 40 75 384
41 JHP0132 cytochrome oxidase (cbb3 type) (fixN) HP0144 27 206 209
42 JHP0842 hypothetical protein HP0906 42 29 21
43 JHP0925 hypothetical protein NAH - 130 990
44 JHP0613 hypothetical protein HP0669 69 42 33
45 JHP0565 DNA mismatch repair protein (mutS) HP0621 22 227 82
46 JHP1363 DNA polymerase I (polA) HP1470 30 81 46
47 JHP0489 cag island protein (cagH) HP0541 71 137 398
48 JHP1260 siderophore-mediated iron transport protein (tonB) HP1341 85 1260 402
49 JHP0492 DNA transfer protein (cagE) HP0544 104 95 50
50 JHP1121 DNA-directed RNA polymerase, beta subunit (rpoB) HP1198 84 23 16
51 JHP1434 DNA repair protein (recN) HP1393 35 177 160
52 JHP0491 cag island protein (cagF) HP0543 82 170 828
53 JHP0191 hypothetical protein HP0205 57 33 7
Genes with > 2 SD divergence indicated in bold
NAH indicates No Annotated Homologue in the other sequencePage 3 of 16
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BMC Genomics 2005, 6:9 http://www.biomedcentral.com/1471-2164/6/9Table 4: Top 60 most divergent (>2 SD) genes by DNS in H. pylori strain 26695 plus those additional genes in the top 50 genes from 
TNS and HNS
DNS order annotation HP# J99 # J99 DNS order TNS order HNS order
1 cag pathogenicity island protein (cag7) HP0527 JHP0476 2 1 1
2 vacuolating cytotoxin (vacA) paralog HP0289 JHP0274 4 2 4
3 poly E-rich hypothetical protein HP0322 JHP0305 5 8 5
4 hypothetical protein HP0609 JHP0556* 3 6 9
5 hypothetical protein HP0996 JHP0942 6 14 46
6 vacuolating cytotoxin (vacA) paralog HP0922 JHP0856 7 5 3
7 hypothetical protein HP0488 JHP0440 13 10 12
8 hypothetical protein HP1116 JHP1044 10 11 13
9 hypothetical protein HP0080 JHP0074 12 18 122
10 hypothetical protein HP0489 JHP0441 115 36 582
11 cag pathogenicity island protein (cag3) HP0522 JHP0471 21 48 100
12 hypothetical protein HP1089 JHP0336 27 67 59
13 vacuolating cytotoxin (vacA) paralog HP0610 JHP0556* 3 12 17
14 hypothetical protein HP0427 JHP0952 1 3 737
15 hypothetical protein HP1408 JHP1300 9 4 738
16 type III restriction enzyme R protein (res) HP0592 NAH - 30 35
17 hypothetical protein HP0119 NAH - 7 2
18 vacuolating cytotoxin (vacA) HP0887 JHP0819 59 25 34
19 N-methylhydantoinase HP0696 JHP0632 20 35 43
20 hypothetical protein HP1115 JHP1042 14 33 866
21 urease beta subunit (urea amidohydrolase) (ureB) HP0072 JHP0067 32 38 87
22 DNA mismatch repair protein (MutS) HP0621 JHP0565 45 137 64
23 cag island protein (cagT) HP0532 JHP0481 25 87 693
24 hypothetical protein HP0756 JHP0693 19 71 1548
25 integrase/recombinase (xerD) HP0995 JHP0941 33 39 448
26 outer membrane protein HP0486 JHP0438 22 147 142
27 cytochrome oxidase (cbb3 type) (fixN) HP0144 JHP0132 41 102 168
28 type IIS restriction enzyme R and M protein (ECO57IR) HP1517 NAH - 42 14
29 DNA transfer protein (cagE) HP0441 JHP0492 49 51 22
30 DNA polymerase I (polA) HP1470 JHP1363 46 77 54
31 cag island protein (cagA) HP0547 JHP0495 17 15 7
32 iron(III) dicitrate transport protein (fecA) HP1400 JHP1426 28 99 129
33 flagellin A (flaA) HP0601 JHP0548 34 40 180
34 outer membrane protein (omp26) HP1157 JHP1084 24 17 25
35 DNA repair protein (recN) HP1393 JHP1434 51 154 207
36 type I restriction enzyme R protein (hsdR) HP0464 NAH - 90 26
37 cell division protein (ftsK) HP1090 JHP0335 67 181 90
38 hypothetical protein HP1003 NAH - 61 170
39 histidine-rich, metal binding polypeptide (hpn) HP1427 NAH - 26 1449
40 hypothetical protein HP1333 JHP1253 40 53 296
41 hypothetical protein HP0788 JHP0725 68 72 256
42 hypothetical protein HP0906 JHP0842 42 22 16
43 hypothetical protein HP0059 JHP0052 26 21 320
44 GMP reductase (guaC) HP0854 JHP0790 107 169 451
45 hypothetical protein HP0030 JHP0026 23 24 39
46 histidine and glutamine-rich metal-binding protein HP1432 JHP1321 15 9 1432
47 hypothetical protein HP0186 JHP0174 29 130 276
48 fucosyltransferase HP0651 JHP0596 105 43 75
49 translation elongation factor EF-Tu (tufB) HP1205 JHP1128 81 64 166
50 virulence associated protein homolog (vacB) HP1248 JHP1169 79 164 160
51 hypothetical protein HP0449 NAH - 81 449
52 type III restriction enzyme R protein HP1371 JHP1285 55 119 23
53 virB4 homolog (virB4) HP0459 NAH - 49 28
54 2',3'-cyclic-nucleotide 2'-phosphodiesterase (cpdB) HP0104 JHP0096 56 73 68
55 hypothetical protein HP1479 JHP1372 135 153 127
56 RNA polymerase sigma-70 factor (rpoD) HP0088 JHP0081 62 55 31
57 hypothetical protein HP0205 JHP0191 53 78 8
58 hypothetical protein HP1143 JHP1071 78 29 41Page 4 of 16
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BMC Genomics 2005, 6:9 http://www.biomedcentral.com/1471-2164/6/9from universally true. There are many instances of single
genes or small numbers of genes that are present that are
not associated with any features that might otherwise
have been used as indicators of horizontal acquisition
such as transposases and flanking repeats.
Our initial goal was to identify recently acquired and
exchanged genes as candidates likely to be important in
niche-adaptation, host interactions, and alterations in
bacterial fitness. It has been argued that essential genes are
unlikely to be transferred successfully since recipient taxa
would already bear functional orthologues, which would
have experienced long-term co-evolution with the rest of
the cellular machinery. In contrast, it is proposed that
those under weak or transient selection – like those asso-
ciated with nonessential catabolic processes, new oper-
ons, and those providing new niche-adaptive changes are
likely to be successfully transferred and retained [19]. This
leads to a model in which a stable 'core genome' com-
prised of essential metabolic, regulatory, and cell division
genes provides a stable context for the more labile non-
essential and niche adaptive genes. On this basis such
genes are used for phylogenetic studies and are thought to
provide a relatively constant background in which species
evolution occurs. Many of the genes identified for which
functions are known affect virulence or niche adaptive
genes, including: the vacuolating cytotoxin and related
toxins (2 and 3), urease and flagellar components, and
genes involved in iron acquisition. However, we also find
clear evidence, confirmed by differences between the two
59 hypothetical protein HP1106 JHP1033 36 272 277
60 cag pathogenicity island protein (cag13) HP0534 JHP0482 71 225 1021
63 DNA topoisomerase I (topA) HP0440 NAH - 149 24
68 outer membrane protein (omp3) HP0079 JHP0073 796 45 99
69 hypothetical protein HP0669 JHP0613 44 60 42
74 cag pathogenicity island protein (cag8) HP0528 JHP0477 72 50 27
75 hypothetical protein HP0453 NAH - 58 10
84 DNA-directed RNA polymerase, beta subunit (rpoB) JHP1121 50 23 19
91 hypothetical protein HP1142 JHP1070 60 19 6
97 multidrug resistance protein (spaB) HP0600 JHP0547 75 41 30
103 type I restriction enzyme R protein (hsdR) HP1402 JHP1424 195 86 21
109 adenine/cytosine DNA methyltransferase HP0054 NAH - 120 20
119 preprotein translocase subunit (secA) HP0786 JHP0723 159 176 49
121 hypothetical protein HP0058 JHP0051 394 16 53
122 hypothetical protein HP0513 JHP0462 104 28 15
125 type I restriction enzyme M protein (hsdM) HP1403 JHP1423 299 340 44
132 hypothetical protein HP0731 JHP0668 110 80 32
139 hypothetical protein HP0508 JHP0458 84 32 77
142 hypothetical protein HP1187 JHP1113 274 31 38
167 hypothetical protein HP1520 NAH - 20 33
179 hypothetical protein HP0118 JHP0110 64 27 36
195 type III restriction enzyme R protein (res) HP1521 JHP1410 161 210 18
209 outer membrane protein (omp17) HP0725 JHP0662 257 47 101
224 hypothetical protein HP0733 JHP0670 769 222 48
230 hypothetical protein HP0611 JHP0299 35 37 1129
249 hypothetical protein HP0345 NAH - 46 1338
283 hypothetical protein HP0120 NAH - 44 50
291 translation initiation factor IF-2 (infB) HP1048 JHP0377 330 332 45
297 DNA polymerase III alpha-subunit (dnaE) HP1460 JHP1353 509 219 47
342 type I restriction enzyme R protein (hsdR) HP0846 JHP0784 244 101 37
363 adenine specific DNA methyltransferase (mod) HP1522 JHP1411 857 207 11
410 secreted protein involved in flagellar motility HP1192 JHP1117 614 13 1256
593 hypothetical protein HP1516 NAH - 34 1090
631 hypothetical protein HP0586 JHP0534 577 163 29
1080 type II restriction enzyme (methyltransferase) HP0478 JHP0430 953 220 40
* probably frame shifted components of the same vacA related gene
Genes with > 2 SD divergence in each analysis are indicated in bold
NAH indicates No Annotated Homologue in the other sequence
Table 4: Top 60 most divergent (>2 SD) genes by DNS in H. pylori strain 26695 plus those additional genes in the top 50 genes from 
TNS and HNS (Continued)Page 5 of 16
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Comparisons using LAlign between a representative selection of orthologous genes with divergent DNA present in both H. 
pylori strains J99 and 26695 (presented in descending order of divergence as determined in strain J99).
a. JHP0305 hypothetical protein (5th)
b. JHP0942 hypothetical protein (6th)
c. JHP1044 hypothetical protein (10th)
d. JHP0440 hypothetical protein (13th)
e. JHP1084 outer membrane protein (24th)
f. JHP0941 xerD family (33rd)
g. JHP1363 polA (46th)
h. JHP1121 rpoB (50th)
i. JHP0081 rpoD (62nd, HNS 37th)
j. JHP0335 ftsK (67th, 37th in strain 26695) 
k. JHP1113 hypothetical protein (274th, 28th in strain 26695) 
l. JHP0073 omp3 (796th, 68th in strain 26695)Page 6 of 16
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BMC Genomics 2005, 6:9 http://www.biomedcentral.com/1471-2164/6/9Table 2: Top 50 most divergent genes by TNS in H. pylori strain J99 plus those additional genes > 2 SD greater than the mean by DNS 
and the 50 most divergent by HNS
TNS order Annotation JHP # 26695 # DNS order HNS order
1 hypothetical protein JHP1300 HP1408 9 1
2 cag pathogenicity island protein (cag7) JHP0476 HP0527 2 2
3 hypothetical protein JHP0952 HP0427 1 1355
4 histidine and glutamine-rich metal-binding protein JHP1321 HP1432 15 49
5 vacuolating cytotoxin (vacA) paralog JHP0556 HP0609/10 3 4
6 vacuolating cytotoxin (vacA) paralog JHP0274 HP0289 4 5
7 hypothetical protein JHP0050 HP0058 8 84
8 hypothetical protein JHP0305 HP0322 5 10
9 vacuolating cytotoxin (vacA) paralog JHP0856 HP0922 7 6
10 type I restriction enzyme (hsdS) JHP1422 NAH 319 3
11 hypothetical protein JHP0299 HP061/2 35 275
12 hypothetical protein JHP0928 NAH 11 9
13 hypothetical protein JHP0942 HP0996 6 27
14 hypothetical protein JHP1044 HP1116 10 8
15 hypothetical protein JHP0934 NAH 16 95
16 hypothetical protein JHP0440 HP0488 13 17
17 outer membrane protein (omp26) JHP1084 HP1157 24 24
18 topoisomerase I (topA 3) JHP0931 NAH 18 20
19 hypothetical protein JHP0318 NAH 286 293
20 cag island protein (cagA) JHP0495 HP0547 17 12
21 hypothetical protein JHP0110 HP0118 64 19
22 hypothetical protein JHP1208 HP1288 91 830
23 DNA-directed RNA polymerase, beta subunit (rpoB) JHP1121 HP1198 50 16
24 hypothetical protein JHP0052 HP0059 26 120
25 hypothetical protein JHP1042 HP1115 14 694
26 hypothetical protein JHP0953 NAH 31 1463
27 hypothetical protein JHP1070 HP1142 60 14
28 hypothetical protein JHP1113 HP1187 274 39
29 hypothetical protein JHP0842 HP0906 42 21
30 type II restriction enzyme JHP0630 NAH 173 588
31 histidine-rich, metal binding polypeptide (hpn) JHP1320 HP1427 70 1404
32 hypothetical protein JHP0074 HP0080 12 125
33 hypothetical protein JHP0191 HP0205 53 7
34 hypothetical protein JHP0376 HP1049 235 1128
35 cag pathogenicity island protein (cag3) JHP0471 HP0522 21 62
36 hypothetical protein JHP0026 HP0030 23 64
37 urease beta subunit (urea amidohydrolase) (ureB) JHP0067 HP0072 32 70
38 hypothetical protein JHP0939 HP0991 116 156
39 multidrug resistance protein (spaB) JHP0547 HP0600 75 18
40 flagellin A (flaA) JHP0548 HP0601 34 154
41 hypothetical protein JHP1071 HP1143 78 61
42 hypothetical protein JHP0613 HP0669 44 33
43 hypothetical protein JHP0623 HP0682 231 1186
44 N-methylhydantoinase JHP0632 HP0696 20 36
45 hypothetical protein JHP1049 NAH 278 470
46 vacuolating cytotoxin (vacA) JHP0819 HP0887 59 38
47 putative restriction enzyme JHP0164 NAH 88 43
48 type I restriction enzyme R protein (hsdR) JHP0784 HP0846 244 35
49 hook assembly protein, flagella (flgD) JHP0843 HP0907 103 175
50 hypothetical protein JHP0458 HP0508 84 44
51 hypothetical protein JHP0336 HP1089 27 54
53 hypothetical protein JHP0940 NAH 39 393
54 hypothetical protein JHP0462 HP0513 104 11
55 type II restriction enzyme (methyltransferase) JHP1409 NAH 37 15
58 hypothetical protein JHP1285 HP1371 55 25
59 hypothetical protein JHP0693 HP0756 19 1490
62 cag pathogenicity island protein (cag8) JHP0477 HP0528 72 31Page 7 of 16
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BMC Genomics 2005, 6:9 http://www.biomedcentral.com/1471-2164/6/9genome sequences, that recent, and therefore relatively
frequent, horizontal transfer is not limited to genes asso-
ciated with niche adaptation and virulence. Amongst the
core function genes identified were mutS, ftsK, xerD, and
polA. The comparisons of the latter three between the
sequence strains are shown in Figure 1f,g &1j. These com-
parisons support the results suggesting that these genes
have been the substrates for horizontal exchange between
species.
Tetranucleotide composition has been used for the con-
sideration of the presence of palindromic sequences that
might be substrates for restriction systems and Chi sites
and the presence of unstable repeats mediating phase var-
iation [10], but the use of longer component signatures
has not been used to identify horizontally acquired
regions in bacterial genomes. Following analysis of
eukaryotic sequences it was concluded that DNS captures
most of the departure from randomness in DNA
sequences and that longer component lengths correlate
highly with the DNS results [20]. Also, analysis of dinucle-
otides separated by no, one, or two other nucleotides
showed that separated pairs are more nearly random than
adjacent pairs and were concluded to be relatively
uninformative [9]. However, in preliminary analyses,
while results using the typically long walking windows
gave concordant results as previously reported, we found
that the use of smaller walking windows generated pro-
gressively more different patterns of divergence with other
length components. Using tetranucleotide (TNS) and hex-
anucleotide (HNS) signature analysis we find that, while
in some instances there is significant overlap between the
genes identified using the different component lengths,
there are substantial differences that indicate additional
horizontally transferred genes not identified by DNS
alone (Tables 2 to 6).
63 type III restriction enzyme (res) JHP1297 NAH 30 28
64 hypothetical protein JHP0668 HP0731 110 32
67 outer membrane protein JHP0438 HP0486 22 145
70 cag island protein (cagT) JHP0481 HP0532 25 558
71 RNA polymerase sigma-70 factor (rpoD) JHP0081 HP0088 62 37
75 hypothetical protein JHP1253 HP1333 40 384
78 iron(III) dicitrate transport protein (fecA) JHP1426 HP1400 28 111
81 DNA polymerase I (polA) JHP1363 HP1470 46 46
85 type I restriction enzyme (hsdS) JHP0414 NAH 275 30
88 hypothetical protein JHP0174 HP0187/8/
6
29 90
89 iron(III) dicitrate transport protein (fecA) JHP0626 HP0686 38 47
95 DNA transfer protein (cagE) JHP0492 HP0544 49 50
100 integrase/recombinase (xerD) JHP0941 HP0995 33 541
104 type III restriciton enzyme (mod) JHP1411 HP1522 857 13
105 type I restriction enzyme R protein (hsdR) JHP0416 HP0464 63 29
122 adenine specific DNA methyltransferase (mod) JHP0244 HP0260 236 48
130 hypothetical protein JHP0925 NAH 43 990
137 cag island protein (cagH) JHP0489 HP0541 47 398
138 type I restriction enzyme (hsdR) JHP1424 HP1402 195 22
158 hypothetical protein JHP0540 NAH 674 26
170 cag island protein (cagF) JHP0491 HP0543 52 828
177 DNA repair protein (recN) JHP1434 HP1393 51 160
190 type III restriction enzyme (mod) JHP1296 NAH 121 34
196 role in outermembrane permeability (imp) JHP1138 HP1215/6 208 45
206 cytochrome oxidase (cbb3 type) (fixN) JHP0132 HP0144 41 209
227 DNA mismatch repair protein (mutS) JHP0565 HP0621 45 82
230 hypothetical protein JHP0534 HP0586 577 40
258 type III restriction enzyme (res) JHP1410 HP1521 161 23
262 hypothetical protein JHP1033 HP1106 36 342
281 translation initiation factor IF-2 (infB) JHP0377 HP1048 330 42
290 type II restriction enzyme (methyltrasferase) JHP1284 NAH 750 41
1260 siderophore-mediated iron transport protein (tonB) JHP1260 HP1341 48 402
Genes with > 2 SD divergence in each analysis are indicated in bold
NAH indicates No Annotated Homologue in the other sequence
Table 2: Top 50 most divergent genes by TNS in H. pylori strain J99 plus those additional genes > 2 SD greater than the mean by DNS 
and the 50 most divergent by HNS (Continued)Page 8 of 16
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and top 50 by TNS
HNS order J99 annotation JHP # 26695 # DNS order TNS order
1 hypothetical protein JHP1300 HP1408 9 1
2 cag pathogenicity island protein (cag7) JHP0476 HP0527 2 2
3 type I restriction enzyme (hsdS) JHP1422 NAH 319 10
4 vacuolating cytotoxin (vacA) paralog JHP0556 HP0609/10 3 5
5 vacuolating cytotoxin (vacA) paralog JHP0274 HP0289 4 6
6 vacuolating cytotoxin (vacA) paralog JHP0856 HP0922 7 9
7 hypothetical protein JHP0191 HP0205 53 33
8 hypothetical protein JHP1044 HP1116 10 14
9 hypothetical protein JHP0928 NAH 11 12
10 hypothetical protein JHP0305 HP0322 5 8
11 hypothetical protein JHP0462 HP0513 104 54
12 cag island protein (cagA) JHP0495 HP0547 17 20
13 type III restriciton enzyme (mod) JHP1411 HP1522 857 104
14 hypothetical protein JHP1070 HP1142 60 27
15 type II restriction enzyme (methyltransferase) JHP1409 NAH 37 55
16 DNA-directed RNA polymerase, beta subunit (rpoB) JHP1121 HP1198 50 23
17 hypothetical protein JHP0440 HP0488 13 16
18 multidrug resistance protein (spaB) JHP0547 HP0600 75 39
19 hypothetical protein JHP0110 HP0118 64 21
20 topoisomerase I (topA 3) JHP0931 NAH – check 18 18
21 hypothetical protein JHP0842 HP0906 42 29
22 type I restriction enzyme (hsdR) JHP1424 HP1402 195 138
23 type III restriction enzyme (res) JHP1410 HP1521 161 258
24 outer membrane protein (omp26) JHP1084 HP1157 24 17
25 hypothetical protein JHP1285 HP1371 55 58
26 hypothetical protein JHP0540 NAH 674 158
27 hypothetical protein JHP0942 HP0996 6 13
28 type III restriction enzyme (res) JHP1297 NAH 30 63
29 type I restriction enzyme R protein (hsdR) JHP0416 HP0464 63 105
30 type I restriction enzyme (hsdS) JHP0414 NAH 275 85
31 cag pathogenicity island protein (cag8) JHP0477 HP0528 72 62
32 hypothetical protein JHP0668 HP0731 110 64
33 hypothetical protein JHP0613 HP0669 44 42
34 type III restriction enzyme (mod) JHP1296 NAH 121 190
35 type I restriction enzyme R protein (hsdR) JHP0784 HP0846 244 48
36 N-methylhydantoinase JHP0632 HP0696 20 44
37 RNA polymerase sigma-70 factor (rpoD) JHP0081 HP0088 62 71
38 vacuolating cytotoxin (vacA) JHP0819 HP0887 59 46
39 hypothetical protein JHP1113 HP1187 274 28
40 hypothetical protein JHP0534 HP0586 577 230
41 type II restriction enzyme (methyltrasferase) JHP1284 NAH 750 290
42 translation initiation factor IF-2 (infB) JHP0377 HP1048 330 281
43 restriction enzyme JHP0164 NAH 88 47
44 hypothetical protein JHP0458 HP0508 84 50
45 role in outermembrane permeability (imp) JHP1138 HP1215/6 208 196
46 DNA polymerase I (polA) JHP1363 HP1470 46 81
47 iron(III) dicitrate transport protein (fecA) JHP0626 HP0686 38 89
48 adenine specific DNA methyltransferase (mod) JHP0244 HP0260 236 122
49 histidine and glutamine-rich metal-binding protein JHP1321 HP1432 15 4
50 DNA transfer protein (cagE) JHP0492 HP0544 49 95
54 hypothetical protein JHP0336 HP1089 27 51
62 cag pathogenicity island protein (cag3) JHP0471 HP0522 21 35
64 hypothetical protein JHP0026 HP0030 23 36
70 urease beta subunit (urea amidohydrolase) (ureB) JHP0067 HP0072 32 37
82 DNA mismatch repair protein (mutS) JHP0565 HP0621 45 227
84 hypothetical protein JHP0050 HP0058 8 7
90 hypothetical protein JHP0174 HP0187/8/6 29 88Page 9 of 16
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BMC Genomics 2005, 6:9 http://www.biomedcentral.com/1471-2164/6/9The 50 most divergent J99 ORFs by HNS included 26
(52%) that were not in the 53 (>2 SD) most divergent by
DNS, these included 11 restriction-modification system
genes and 6 others that were not annotated within the
strain 26695 genome sequence. The identification of
genes of a type known to be horizontally exchanged, and
different between the gene complements of the strains, is
strong corroboration for the foreign origin of the addi-
tional genes identified by HNS. In several instances
(Tables 2 to 6) the DNS did not detect these genes at all
e.g. restriction enzymes that were the 3rd, 13th and 41st
most divergent genes by HNS, were 319th, 857th and 750th
most divergent by DNS, respectively. In some instances
the TNS gave intermediate results and in others identified
other genes as more divergent than the other methods.
The TNS was most sensitive for the detection of rpoB
(HP1198 / JHP1121) which is associated with a signifi-
cantly different gene length in the two strains (Figure 1h).
One explanation for this observation is that while the
DNS may initially be the most sensitive indicator of hori-
zontal exchange it may become ameliorated to the new
sequence characteristics more rapidly that the longer
component features, which are probably detecting quali-
tatively different sequence characteristics.
The differences in the analyses using different length com-
ponents, and a comparison of the results from the two
sequenced strains, suggest a complex evolutionary history
for the cag pathogenicity island. These suggest that it
probably has mosaic structure including sequences from
more than one species background, in addition to
sequence that is entirely typical of H. pylori.
It is normally impossible to determine the chronology of
events to distinguish insertions and deletions when
comparing strains. In strain 26695 there are two open
reading frames that are both good candidate coding
sequences. There is only one gene in this location in strain
J99 composed of the 5' gene from strain 26695 and the 3'
end of the subsequent gene. This could have arisen from
either a deletion or an insertion event. However, the nor-
mal DNS of the J99 gene (JHP0073, 799th in divergence)
and the 5' 26695 gene (HP0079, 751st in divergence), and
the high divergence of the 3' 26695 gene (HP0078, 68th in
divergence), indicate that the most likely event is an inser-
tion into strain 26695 (Figure 1l). Likewise HP0119 is
likely to contain an insertion and JHP1113 probably
reflects the original sequences (Figure 1k).
The inclusion of two DNA metabolism genes associated
with recombination and repair is notable. Both mutS and
recN were identified in both strains (22nd and 35th, and
45th and 51st most divergent genes by DNS in strains
26695 and J99 respectively). When the homologous genes
were compared between the strains, extensive divergences
were evident between more than one region of each pro-
95 hypothetical protein JHP0934 NAH 16 15
111 iron(III) dicitrate transport protein (fecA) JHP1426 HP1400 28 78
120 hypothetical protein JHP0052 HP0059 26 24
125 hypothetical protein JHP0074 HP0080 12 32
145 Outer membrane protein JHP0438 HP0486 22 67
154 flagellin A (flaA) JHP0548 HP0601 34 40
160 DNA repair protein (recN) JHP1434 HP1393 51 177
209 cytochrome oxidase (cbb3 type) (fixN) JHP0132 HP0144 41 206
275 hypothetical protein JHP0299 HP061/2 35 11
342 hypothetical protein JHP1033 HP1106 36 262
384 hypothetical protein JHP1253 HP1333 40 75
393 hypothetical protein JHP0940 NAH 39 53
398 cag island protein (cagH) JHP0489 HP0541 47 137
402 siderophore-mediated iron transport protein (tonB) JHP1260 HP1341 48 1260
541 integrase/recombinase (xerD) JHP0941 HP0995 33 100
558 cag island protein (cagT) JHP0481 HP0532 25 70
694 hypothetical protein JHP1042 HP1115 14 25
828 cag island protein (cagF) JHP0491 HP0543 52 170
990 hypothetical protein JHP0925 NAH 43 130
1355 hypothetical protein JHP0952 HP0427 1 3
1463 hypothetical protein JHP0953 NAH 31 26
1490 hypothetical protein JHP0693 HP0756 19 59
Genes with > 2 SD divergence in each analysis are indicated in bold
NAH indicates No Annotated Homologue in the other sequence
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DNS and the 50 most divergent by HNS
TNS order annotation HP# J99 # DNS order HNS order
1 cag pathogenicity island protein (cag7) HP0527 JHP0476 1 1
2 vacuolating cytotoxin (vacA) paralog HP0289 JHP0274 2 4
3 hypothetical protein HP0427 JHP0952 14 737
4 hypothetical protein HP1408 JHP1300 15 738
5 vacuolating cytotoxin (vacA) paralog HP0922 JHP0856 6 3
6 hypothetical protein HP0609 JHP0556* 4 9
7 hypothetical protein HP0119 NAH 17 2
8 poly E-rich hypothetical protein HP0322 JHP0305 3 5
9 histidine and glutamine-rich metal-binding protein HP1432 JHP1321 46 1432
10 hypothetical protein HP0488 JHP0440 7 12
11 hypothetical protein HP1116 JHP1044 8 13
12 vacuolating cytotoxin (vacA) paralog HP0610 JHP0556* 13 17
13 secreted protein involved in flagellar motility HP1192 JHP1117 410 1256
14 hypothetical protein HP0996 JHP0942 5 46
15 cag island protein (cagA) HP0547 JHP0495 31 7
16 hypothetical protein HP0058 JHP0051 121 53
17 outer membrane protein (omp26) HP1157 JHP1084 34 25
18 hypothetical protein HP0080 JHP0074 9 122
19 hypothetical protein HP1142 JHP1070 91 6
20 hypothetical protein HP1520 NAH 167 33
21 hypothetical protein HP0059 JHP0052 43 320
22 hypothetical protein HP0906 JHP0842 42 16
23 DNA-directed RNA polymerase, beta subunit (rpoB) HP1198 JHP1121 84 19
24 hypothetical protein HP0030 JHP0026 45 39
25 vacuolating cytotoxin (vacA) HP0887 JHP0819 18 34
26 histidine-rich, metal binding polypeptide (hpn) HP1427 NAH 39 1449
27 hypothetical protein HP0118 JHP0110 179 36
28 hypothetical protein HP0513 JHP0462 122 15
29 hypothetical protein HP1143 JHP1071 58 41
30 type III restriction enzyme R protein (res) HP0592 NAH 16 35
31 hypothetical protein HP1187 JHP1113 142 38
32 hypothetical protein HP0508 JHP0458 139 77
33 hypothetical protein HP1115 JHP1042 20 866
34 hypothetical protein HP1516 NAH 593 1090
35 N-methylhydantoinase HP0696 JHP0632 19 43
36 hypothetical protein HP0489 JHP0441 10 582
37 hypothetical protein HP0611 JHP0299 230 1129
38 urease beta subunit (urea amidohydrolase) (ureB) HP0072 JHP0067 21 87
39 integrase/recombinase (xerD) HP0995 JHP0941 25 448
40 flagellin A (flaA) HP0601 JHP0548 33 180
41 multidrug resistance protein (spaB) HP0600 JHP0547 97 30
42 type IIS restriction enzyme R and M protein (ECO57IR) HP1517 NAH 28 14
43 fucosyltransferase HP0651 JHP0596 48 75
44 hypothetical protein HP0120 NAH 283 50
45 outer membrane protein (omp3) HP0079 JHP0073 68 99
46 hypothetical protein HP0345 NAH 249 1338
47 outer membrane protein (omp17) HP0725 JHP0662 209 101
48 cag pathogenicity island protein (cag3) HP0522 JHP0471 11 100
49 virB4 homolog (virB4) HP0459 NAH 53 28
50 cag pathogenicity island protein (cag8) HP0528 JHP0477 74 27
51 DNA transfer protein (cagE) HP0441 JHP0492 29 22
53 hypothetical protein HP1333 JHP1253 40 296
55 RNA polymerase sigma-70 factor (rpoD) HP0088 JHP0081 56 31
58 hypothetical protein HP0453 NAH 75 10
60 hypothetical protein HP0669 JHP0613 69 42
61 hypothetical protein HP1003 NAH 38 170
64 translation elongation factor EF-Tu (tufB) HP1205 JHP1128 49 166Page 11 of 16
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BMC Genomics 2005, 6:9 http://www.biomedcentral.com/1471-2164/6/9tein. That these genes have divergent signatures in both
strains suggests that neither has a wholly native composi-
tion. This observation is consistent with the models of
rapid evolution which suggest that transient competitive
advantages are enjoyed by organisms that are hypermuta-
tors under conditions of environmental stress and
transitions, and that these states which can be produced
by mutations in DNA repair genes [21-26]. However, such
states have to be reversed so that an unsustainable muta-
tional burden is not attained, and it has been proposed
that this reversal is mediated by repair following horizon-
tal transfer and homologous recombination, and that
such strains are hyper-recombinogenic [27-29]. The
untypicality of mutS and recN suggest that H. pylori is
another species that can make use of this strategy for
diversification under stressful conditions.
The identification of RNA polymerase genes, with associ-
ated differences between the strains, is striking. The
divergence of phylogenetic trees based upon different
sequences has been highlighted, and particularly the dif-
ferences between the trees associated with RNA polymer-
ase genes and rRNA [30,31]. It has been argued that RNA
polymerase is as essential to cell function as is rRNA and
that there is no compelling reason to chose rRNA as the
more reliable marker [32]. While the DNS analysis does
not address the stability of rRNA (and specifically
excludes the rRNA sequences because their differing cod-
ing requirements and evolutionary pressures generate a
67 hypothetical protein HP1089 JHP0336 12 59
71 hypothetical protein HP0756 JHP0693 24 1548
72 hypothetical protein HP0788 JHP0725 41 256
73 2',3'-cyclic-nucleotide 2'-phosphodiesterase (cpdB) HP0104 JHP0096 54 68
77 DNA polymerase I (polA) HP1470 JHP1363 30 54
78 hypothetical protein HP0205 JHP0191 57 8
80 hypothetical protein HP0731 JHP0668 132 32
81 hypothetical protein HP0449 NAH 51 449
86 type I restriction enzyme R protein (hsdR) HP1402 JHP1424 103 21
87 cag pathogenicity island protein (cag12) HP0532 JHP0481 23 693
90 type I restriction enzyme R protein (hsdR) HP0464 NAH 36 26
99 iron(III) dicitrate transport protein (fecA) HP1400 JHP1426 32 129
101 type I restriction enzyme R protein (hsdR) HP0846 JHP0784 342 37
102 cytochrome oxidase (cbb3 type) (fixN) HP0144 JHP0132 27 168
119 type III restriction enzyme R protein HP1371 JHP1285 52 23
120 adenine/cytosine DNA methyltransferase HP0054 NAH 109 20
130 hypothetical protein HP0186 JHP0174 47 276
137 DNA mismatch repair protein (MutS) HP0621 JHP0565 22 64
147 outer membrane protein HP0486 JHP0438 26 142
149 DNA topoisomerase I (topA) HP0440 NAH 63 24
153 hypothetical protein HP1479 JHP1372 55 127
154 DNA repair protein (recN) HP1393 JHP1434 35 207
163 hypothetical protein HP0586 JHP0534 631 29
164 virulence associated protein homolog (vacB) HP1248 JHP1169 50 160
169 GMP reductase (guaC) HP0854 JHP0790 44 451
176 preprotein translocase subunit (secA) HP0786 JHP0723 119 49
181 cell division protein (ftsK) HP1090 JHP0335 37 90
207 adenine specific DNA methyltransferase (mod) HP1522 JHP1411 363 11
210 type III restriction enzyme R protein (res) HP1521 JHP1410 195 18
219 DNA polymerase III alpha-subunit (dnaE) HP1460 JHP1353 297 47
220 type II restriction enzyme (methyltransferase) HP0478 JHP0430 1080 40
222 hypothetical protein HP0733 JHP0670 224 48
225 cag pathogenicity island protein (cag13) HP0534 JHP0482 60 1021
272 hypothetical protein HP1106 JHP1033 59 277
332 translation initiation factor IF-2 (infB) HP1048 JHP0377 291 45
340 type I restriction enzyme M protein (hsdM) HP1403 JHP1423 125 44
* probably frame shifted components of the same vacA related gene
Genes with > 2 SD divergence in each analysis are indicated in bold
NAH indicates No Annotated Homologue in the other sequence
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DNS and the 50 most divergent by HNS
HNS order annotation HP# J99 # DNS order TNS order
1 cag pathogenicity island protein (cag7) HP0527 JHP0476 1 1
2 hypothetical protein HP0119 NAH 17 7
3 vacuolating cytotoxin (vacA) paralog HP0922 JHP0856 6 5
4 vacuolating cytotoxin (vacA) paralog HP0289 JHP0274 2 2
5 poly E-rich hypothetical protein HP0322 JHP0305 3 8
6 hypothetical protein HP1142 JHP1070 91 19
7 cag island protein (cagA) HP0547 JHP0495 31 15
8 hypothetical protein HP0205 JHP0191 57 78
9 hypothetical protein HP0609 JHP0556* 4 6
10 hypothetical protein HP0453 NAH 75 58
11 adenine specific DNA methyltransferase (mod) HP1522 JHP1411 363 207
12 hypothetical protein HP0488 JHP0440 7 10
13 hypothetical protein HP1116 JHP1044 8 11
14 type IIS restriction enzyme R and M protein (ECO57IR) HP1517 NAH 28 42
15 hypothetical protein HP0513 JHP0462 122 28
16 hypothetical protein HP0906 JHP0842 42 22
17 vacuolating cytotoxin (vacA) paralog HP0610 JHP0556* 13 12
18 type III restriction enzyme R protein (res) HP1521 JHP1410 195 210
19 DNA-directed RNA polymerase, beta subunit (rpoB) HP1198 JHP1121 84 23
20 adenine/cytosine DNA methyltransferase HP0054 NAH 109 120
21 type I restriction enzyme R protein (hsdR) HP1402 JHP1424 103 86
22 DNA transfer protein (cagE) HP0441 JHP0492 29 51
23 type III restriction enzyme R protein HP1371 JHP1285 52 119
24 DNA topoisomerase I (topA) HP0440 NAH 63 149
25 outer membrane protein (omp26) HP1157 JHP1084 34 27
26 type I restriction enzyme R protein (hsdR) HP0464 NAH 36 90
27 cag pathogenicity island protein (cag8) HP0528 JHP0477 74 50
28 virB4 homolog (virB4) HP0459 NAH 53 49
29 hypothetical protein HP0586 JHP0534 631 163
30 multidrug resistance protein (spaB) HP0600 JHP0547 97 41
31 RNA polymerase sigma-70 factor (rpoD) HP0088 JHP0081 56 55
32 hypothetical protein HP0731 JHP0668 132 80
33 hypothetical protein HP1520 NAH 167 20
34 vacuolating cytotoxin HP0887 JHP0819 18 25
35 type III restriction enzyme R protein (res) HP0592 NAH 16 30
36 hypothetical protein HP0118 JHP0110 179 27
37 type I restriction enzyme R protein (hsdR) HP0846 JHP0784 342 101
38 hypothetical protein HP1187 JHP1113 142 31
39 hypothetical protein HP0030 JHP0026 45 24
40 HP0478 JHP0430 1080 220
41 hypothetical protein HP1143 JHP1071 58 29
42 hypothetical protein HP0669 JHP0613 69 60
43 N-methylhydantoinase HP0696 JHP0632 19 35
44 type I restriction enzyme M protein (hsdM) HP1403 JHP1423 125 340
45 translation initiation factor IF-2 (infB) HP1048 JHP0377 291 332
46 hypothetical protein HP0996 JHP0942 5 14
47 DNA polymerase III alpha-subunit (dnaE) HP1460 JHP1353 297 219
48 hypothetical protein HP0733 JHP0670 224 222
49 preprotein translocase subunit (secA) HP0786 JHP0723 119 176
50 hypothetical protein HP0120 NAH 283 44
53 hypothetical protein HP0058 JHP0051 121 16
54 DNA polymerase I (polA) HP1470 JHP1363 30 77
59 hypothetical protein HP1089 JHP0336 12 67
64 DNA mismatch repair protein (MutS) HP0621 JHP0565 22 137
68 2',3'-cyclic-nucleotide 2'-phosphodiesterase (cpdB) HP0104 JHP0096 54 73
75 fucosyltransferase HP0651 JHP0596 48 43
77 hypothetical protein HP0508 JHP0458 139 32Page 13 of 16
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BMC Genomics 2005, 6:9 http://www.biomedcentral.com/1471-2164/6/9divergent signature for other reasons), it does indicate that
RNA polymerase can be a substrate for horizontal transfer,
and that trees based upon this gene, or other essential
genes, need not necessarily be considered a challenge to
rRNA based phylogenies.
Conclusions
The spectrum of recently horizontally acquired sequences
identified emphasizes the two driving forces of horizontal
exchange: the transfer of a phenotype which alters or
enhances bacterial fitness resulting in increased competi-
tive fitness or altered niche adaptation, and the presence
of a substrate for homologous recombination. Because of
the focus upon, and relative ease of identifying, large
islands associated with readily identifiable features and
phenotypes, the importance of the latter component has
perhaps been underestimated. The genes that have been
considered to code for 'core metabolic' 'house-keeping'
functions are amongst those most likely to be changed by
horizontal transfer events because of the presence of
homologous substrates, and changes are likely to persist
even when the change is phenotypically neutral. Equally,
changes in the genes involved in core functions such as
gene expression and DNA metabolism may have pleo-
tropic effects and there may be significant differences in
strain behaviour, that are not simply the consequence of
differences in their respective gene complements. The
selection of genes for phylogenetic analysis on the basis of
their coding for conserved core functions is also problem-
atic because these are also frequently the genes most likely
to share the high homology that facilitates recombination
and horizontal exchange.
87 urease beta subunit (urea amidohydrolase) (ureB) HP0072 JHP0067 21 38
90 cell division protein (ftsK) HP1090 JHP0335 37 181
99 outer membrane protein (omp3) HP0079 JHP0073 68 45
100 cag pathogenicity island protein (cag3) HP0522 JHP0471 11 48
101 outer membrane protein (omp17) HP0725 JHP0662 209 47
122 hypothetical protein HP0080 JHP0074 9 18
127 hypothetical protein HP1479 JHP1372 55 153
129 iron(III) dicitrate transport protein (fecA) HP1400 JHP1426 32 99
142 outer membrane protein HP0486 JHP0438 26 147
160 virulence associated protein homolog (vacB) HP1248 JHP1169 50 164
166 translation elongation factor EF-Tu (tufB) HP1205 JHP1128 49 64
168 cytochrome oxidase (cbb3 type) (fixN) HP0144 JHP0132 27 102
170 hypothetical protein HP1003 NAH 38 61
180 flagellin A (flaA) HP0601 JHP0548 33 40
207 DNA repair protein (recN) HP1393 JHP1434 35 154
256 hypothetical protein HP0788 JHP0725 41 72
276 hypothetical protein HP0186 JHP0174 47 130
277 hypothetical protein HP1106 JHP1033 59 272
296 hypothetical protein HP1333 JHP1253 40 53
320 hypothetical protein HP0059 JHP0052 43 21
448 integrase/recombinase (xerD) HP0995 JHP0941 25 39
449 hypothetical protein HP0449 NAH 51 81
451 GMP reductase (guaC) HP0854 JHP0790 44 169
582 hypothetical protein HP0489 JHP0441 10 36
693 cag island protein (cagT) HP0532 JHP0481 23 87
737 hypothetical protein HP0427 JHP0952 14 3
738 hypothetical protein HP1408 JHP1300 15 4
866 hypothetical protein HP1115 JHP1042 20 33
1021 cag pathogenicity island protein (cag13) HP0534 JHP0482 60 225
1090 hypothetical protein HP1516 NAH 593 34
1129 hypothetical protein HP0611 JHP0299 230 37
1256 secreted protein involved in flagellar motility HP1192 JHP1117 410 13
1338 hypothetical protein HP0345 NAH 249 46
1432 histidine and glutamine-rich metal-binding protein HP1432 JHP1321 46 9
1449 histidine-rich, metal binding polypeptide (hpn) HP1427 NAH 39 26
1548 hypothetical protein HP0756 JHP0693 24 71
* probably frame shifted components of the same vacA related gene
Genes with > 2 SD divergence in each analysis are indicated in bold
NAH indicates No Annotated Homologue in the other sequence
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A traditional nucleotide signature is generated by seg-
menting a sequence of DNA into k equal-sized subse-
quences (or 'windows'). The mathematical basis for the
signature is an odds ratio – pi – calculated by dividing the
frequency of a length-L oligonucleotide by its expected
frequency. The odds ratios for each of the 4L oligonucle-
otides in each window (w) are compared with the odds
ratios for the overall sequence (s) [9,10,33]. The normal-
ized difference δ is plotted and thus a nucleotide signature
consists of a k-length sequence of δ values: δ(w,s) = (1/
4L)Σ(4L,i:x)|pi(w) - pi(s)|, where x is the set of all permuta-
tions of length L and i is one such permutation.
There are interesting parallels between signature-style
genome analysis and stylometric techniques previously
used to determine the authorship of controversial literary
texts. This is analogous with the biological problem and it
is from this that our method is derived. Rather than using
a fixed-window signature, signature scores are calculated
for each coding open reading frame (ORF) and weighted
with variance estimates so that the scores for shorter ORFs
confer with their longer counterparts. Bissell's weighted
cusum (cumulative sum) [34],
, is modi-
fied so that n denotes the number of ORFs in the genome,
Xi the number of oligonucleotides in ORF i, and wi the
number of nucleotides in ORF i. The results are scaled
according to ORF size using the standard error σ =
√( *#ORF). In this way false positives are abrogated by
normalizing for over-representation of lower order
peptides.
The method is implemented in Java and efficiency is
maintained through an O(N) (N = sequence length)
refinement: probabilities for the complete sequence are
calculated in O(N) steps for any length-L oligonucleotide,
and maintain O(N) when 4L>N through a hashing func-
tion; the second part of the program calculates σ for each
ORF using a loop flattening technique, thereby avoiding
the program having to recalculate overlapping sub-expres-
sions. The program is available from ftp://ftp.dcs.war
wick.ac.uk/people/Stephen.Jarvis/ and http://www.mol
biol.ox.ac.uk/~saunders/.
Sequence alignments, as shown in Figure 1, were per-
formed and displayed using the programs: Lalign and
viewed using Lalignview [35].
Abbreviations
ORF, Open Reading Frame; DNS, Dinucleotide Signature;
TNS, tetranucleotide signature; HNS, hexanucleotide
signature.
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